Pharmaceutical product overview
| Indication | Product | Nine Months 2008 sales | |
|---|---|---|---|
Click here for further information |
Click on product name for further information | USD m | variance in USD |
| Alzheimer's disease |  |
606 |
31% |
| Parkinson's disease |  |
376 |
24% |
| Epilepsy |  |
354 |
16% |
| Attention deficit disorder |   |
320 |
18% |
| Epilepsy |  |
259 |
-56% |
| Indication | Product | Nine Months 2008 sales | |
|---|---|---|---|
| Click here for further information |
Click on product name for further information | USD m | variance in USD |
| Hypertension |   |
4321 |
18% |
| Cholesterol reduction |  |
496 |
-1% |
| Hypertension |  |
296 |
-55% |
| Hypertension |  |
288 |
454% |
| Indication | Product | Nine Months 2008 sales | |
|---|---|---|---|
| Click here for further information |
Click on product name for further information | USD m | variance in USD |
| Asthma |  |
306 |
15% |
| Cystic Fibrosis | Tobramycin |
219 |
9% |
| Indication | Product | Nine Months 2008 sales | |
|---|---|---|---|
| Click here for further information |
Click on product name for further information | USD m | variance in USD |
| Transplantation |  |
738 |
5% |
| Transplantation |  |
219 |
60% |
| Indication | Product | Nine Months 2008 sales | |
|---|---|---|---|
| Click here for further information |
Click on product name for further information | USD m | variance in USD |
| Chronic myeloid leukemia |  |
2780 |
26% |
| Cancer complications |  |
1037 |
9% |
| Acromegaly |  |
852 |
14% |
| Breast cancer |  |
850 |
25% |
| Iron chelator |  |
386 |
51% |
| Indication | Product | Nine Months 2008 sales | |
|---|---|---|---|
| Click here for further information |
Click on product name for further information | USD m | variance in USD | Inflammation / pain |  |
624 |
13% |
| Indication | Product | Nine Months 2008 sales | |
|---|---|---|---|
| Click here for further information |
Click on product name for further information | USD m | variance in USD |
| Age-related macular degeneration |  |
658 |
195% |
Quarterly results
View and download the latest quarterly reports from Novartis.
Corporate publications
